Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amera Halabi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cardiovascular Diabetology|August 8, 2020
Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysisAmera Halabi, Jonathan Sen, Quan Huynh, et al.
Journal of Diabetes and Its Complications|March 23, 2021
Role of microvascular dysfunction in left ventricular dysfunction in type 2 diabetes mellitusAmera Halabi, Mark Nolan, Elizabeth Potter, et al.
ESC Heart Failure|July 23, 2021
Use of novel non-invasive techniques and biomarkers to guide outpatient management of fluid overload and reduce hospital readmission: systematic review and meta-analysisGeorgios Zisis, Amera Halabi, Quan Huynh, et al.
JACC. Cardiovascular Imaging|November 22, 2020
Evolution of Myocardial Dysfunction in Asymptomatic Patients at Risk of Heart FailureAmera Halabi, Hilda Yang, Leah Wright, et al.
Cardiovascular Diabetology|May 30, 2025
Effects of dapagliflozin on the progression of left ventricular dysfunction in type 2 diabetes mellitus: a randomized controlled trialThomas H Marwick, Amera Halabi, Cheng Hwee Soh, et al.
Cardiovascular Diabetology|December 9, 2022
Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitusAmera Halabi, Elizabeth Potter, Hilda Yang, et al.
Cardiovascular Diabetology|March 6, 2024
Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitusCheng Hwee Soh, Alex G C de Sá, Elizabeth Potter, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
Has invasive management for acute coronary syndromes become more 'risk-appropriate': pooled results of five Australian registriesAmera Halabi, Derek P Chew, Matthew Horsfall, et al.
Emergency Medicine Australasia : EMA|June 3, 2017
Rational clinical evaluation of suspected acute coronary syndromes: The value of more informationDavid G Hancock, Ming-Yu Anthony Chuang, Rebecca Bystrom, et al.
International Journal of Cardiology|July 25, 2018
Invasive management of acute coronary syndrome: Interaction with competing risksAnthony Ming-Yu Chuang, David G Hancock, Amera Halabi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cardiovascular Diabetology|August 8, 2020
Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysisAmera Halabi, Jonathan Sen, Quan Huynh, et al.
Journal of Diabetes and Its Complications|March 23, 2021
Role of microvascular dysfunction in left ventricular dysfunction in type 2 diabetes mellitusAmera Halabi, Mark Nolan, Elizabeth Potter, et al.
ESC Heart Failure|July 23, 2021
Use of novel non-invasive techniques and biomarkers to guide outpatient management of fluid overload and reduce hospital readmission: systematic review and meta-analysisGeorgios Zisis, Amera Halabi, Quan Huynh, et al.
JACC. Cardiovascular Imaging|November 22, 2020
Evolution of Myocardial Dysfunction in Asymptomatic Patients at Risk of Heart FailureAmera Halabi, Hilda Yang, Leah Wright, et al.
Cardiovascular Diabetology|May 30, 2025
Effects of dapagliflozin on the progression of left ventricular dysfunction in type 2 diabetes mellitus: a randomized controlled trialThomas H Marwick, Amera Halabi, Cheng Hwee Soh, et al.
Cardiovascular Diabetology|December 9, 2022
Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitusAmera Halabi, Elizabeth Potter, Hilda Yang, et al.
Cardiovascular Diabetology|March 6, 2024
Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitusCheng Hwee Soh, Alex G C de Sá, Elizabeth Potter, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 21, 2017
Has invasive management for acute coronary syndromes become more 'risk-appropriate': pooled results of five Australian registriesAmera Halabi, Derek P Chew, Matthew Horsfall, et al.
Emergency Medicine Australasia : EMA|June 3, 2017
Rational clinical evaluation of suspected acute coronary syndromes: The value of more informationDavid G Hancock, Ming-Yu Anthony Chuang, Rebecca Bystrom, et al.
International Journal of Cardiology|July 25, 2018
Invasive management of acute coronary syndrome: Interaction with competing risksAnthony Ming-Yu Chuang, David G Hancock, Amera Halabi, et al.
Pageof 2